Article info

Download PDFPDF

Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis
Free
  1. Mr C D Johnson, Reader in Surgery, Southampton General Hospital (Mail point 816), Southampton SO16 6YD, UK.c.d.johnson{at}soton.ac.uk
View Full Text

Citation

Johnson CD, Kingsnorth AN, Imrie CW, et al
Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis

Publication history

  • Accepted June 22, 2000
  • First published January 1, 2001.
Online issue publication 
January 01, 2001

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.